Advertisement
Advertisement

TIL

TIL logo

Instil Bio Inc

19.93
USD
-1.76
-8.11%
Dec 18, 15:59 UTC -5
Closed
...

Instil Bio Inc Profile

About

Instil Bio Inc. is a clinical-stage biopharmaceutical company. It is focused on developing an innovative cell therapy pipeline of autologous TIL therapies for the treatment of patients with cancer. Instil Bio Inc. is based in DALLAS.

Info & Links

CEO

Bronson Crouch

Headquarters

3963 MAPLE AVENUE, SUITE 350
DALLAS, TX 75219, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

17

Employees

49

Instil Bio Inc Statistics

Valuation Measures

Market Capitalization2

130.14M

Enterprise Value

205.65M

Enterprise Value/EBITDA(ttm)

-2.90

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.81

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-37.44%

Return on Invested Capital(ttm)

-26.95%

Return on Assets(ttm)

-25.08%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-70.84M

Net Income Available to Common(ttm)

-75.17M

Diluted EPS(ttm)

-11.56

Share Statistics

Beta (5Y Monthly)

1.60

52-Week Change

193.09%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

6.53M

Dividend Yield

0.00%

Float4

3.49M

% Held by Insiders

46.50%

% Held by Institutions

60.56%

Balance Sheet

Total Cash(mrq)

120.35M

Total Cash Per Share(mrq)

18.44

Total Debt(mrq)

82.17M

Total Debt/Equity(mrq)

46.60%

Current Ratio(mrq)

12.90%

Quick Ratio(mrq)

12.90%

Book Value Per Share(mrq)

27.02

Cash Flow

Operating Cash Flow Per Share(ytd)

-6.94

Free Cash Flow(ytd)

-45.14M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement